• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

Maternal and Foetal Outcome in Placenta Previa

    Dr. Harshita Chouhan, Dr. Deepti Gupta, Dr. Hansa Thagele

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 4311-4316

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The aim of this study is tostudy the Maternal and Foetal Outcome in Placenta Previa.
In this retrospective study, 36 cases of placenta praevia who underwent caesarean section from a time period of 2 years in tertiary centre were taken. All cases of APH in whom diagnosis of placenta praevia was made clinically and/or confirmed by abdominal ultrasound were included in the study. In all these cases care was taken to exclude other causes of APH.
Result: 21 cases (39.08%) cases of placenta praevia had no history of previous uterine surgery while 60.92 % had history of previous uterine surgery. In present study, 39.08 % placenta praevia occurred in patients without any history of previous uterine surgery, out of which 18.39 % were primigravida , 20.63 % were multigravida. In present study, 27.58% were complicated. Most common was PPH, DIC, Bladder injury and placental bed bleeding.
Conclusion: In our series , the major contributing factors in etiology of placenta praevia appear to be Multiparity – 66.67 % Previous ceaserean section - 29.88 % Endometrial damage following MTP & Abortion – 43.67%. Careful adoption of conservative measures in suitable cases of Placenta praevia who have no bleeding episodes and when the foetus is still immature should be done only in a tertiary care hospital with emergency operative services and experienced staff and good NICU facilities.
Keywords:
    risk placenta & praevia
  • PDF (271 K)
  • XML
(2023). Maternal and Foetal Outcome in Placenta Previa. European Journal of Molecular & Clinical Medicine, 10(1), 4311-4316.
Dr. Harshita Chouhan, Dr. Deepti Gupta, Dr. Hansa Thagele. "Maternal and Foetal Outcome in Placenta Previa". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 4311-4316.
(2023). 'Maternal and Foetal Outcome in Placenta Previa', European Journal of Molecular & Clinical Medicine, 10(1), pp. 4311-4316.
Maternal and Foetal Outcome in Placenta Previa. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 4311-4316.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 9
  • PDF Download: 9
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus